A sleep medicine physician conducts a crossover study to evaluate the efficacy of a novel non-benzodiazepine hypnotic agent compared to placebo in patients with chronic insomnia. Twenty patients are enrolled. Each patient receives the placebo for one week, undergoes a one-week washout period, and then receives the active medication for one week. The primary outcome is the average sleep onset latency, measured in minutes via polysomnography at the end of each treatment period. A preliminary analysis of the data reveals that the differences in sleep onset latency between the two treatment periods are markedly skewed and do not adhere to a normal distribution. Which of the following statistical tests is most appropriate to determine if there is a significant difference in sleep onset latency between the two treatments?
- Wilcoxon signed-rank testAnswer
- BPaired t-test
- CMann-Whitney U test
- DKruskal-Wallis test
- EMcNemar test